物质信息

ID:1055

名称和标识
商标名
CinnasilNormorescinaRaurescinRescaloidRescaminRescinRescidanResealoidTsuruselpi STuaregRescinpalApoterin SCinatabsRaupyrolAnaprelApolonCinnaloidParesinanRaurescineRecitensinaReskinnaminTenamineAnapralApoterinCartricCinamineModerilRescisanRescitensResipalRozexScinnamina
别名
Methyl TrimethoxycinnamoylreserpateReserpinineRecinnamineReserpineneReserpininRescinnamineTrimethoxycinnamoyl Methyl ReserpateRescinnamin
IUPAC传统名
rescinnamine
IUPAC标准名
methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate
数据登录号
PubChem CID
PubChem SID
化合物性质
理化性质
疏水性(logP)
3.5
描述信息
Drug Groups
approved
Description
Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug. It is an alkaloid obtained from Rauwolfia serpentina and other species of Rauwolfia. [Wikipedia]
Indication
For the treatment of hypertension.
Pharmacology
Used to treat hypertension. Rescinnamine inhibits angiotensin-converting enzyme. ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. Angiotensin II also stimulates aldosterone secretion by the adrenal cortex and general vasoconstriction, both of which lead to increases vascular resistance. By inhibiting angiotensin II, aldosterone reabsorption is decreased as well as vasoconstriction. This combined effect serves to decrease blood pressure.
Affected Organisms
Humans and other mammals
External Links
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据